Qamar Zaman MD in Cumberland, Maryland

Home Maryland Cumberland

Qamar Zaman MD has Hematology/oncology as his primary medical specialty. Their primary office is: 12502 Willowbrook Rd in Cumberland, Maryland. They attended Sorry, his university is not listed and graduated in 1972 (around 52 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Qamar Ul Zaman MD Office Phone and Directions

Qamar Zaman MD
12502 Willowbrook Rd
Cumberland, Maryland 21502
301-777-3111

Patient Ratings
Please rate your experience with Qamar Zaman MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 301-777-3111

Enter a starting address:

Healthcare Info for Qamar Zaman MD

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 1972
The Primary Medical Specialty for Qamar Zaman MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 52
PAC (PECOS ID)#: 8921017997
NPI #: 1093893331
NPI Created On: 11/02/2006
NPI Last Updated Listed as: 02/01/2012
Primary Taxonomy Code: 207RH0003X
License Number:
D0023371
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

CareFirst BlueChoice, Inc.
Humana
Group Hospitalization and Medical Services Inc.
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English,Pakistani/Urdu, Punjabi, Pakistani/Urdu, Punjabi, English, Urdu, Pakistani.

Services and Procedures include:

New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 50 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Prolonged patient service without direct patient contact first hour
Prolonged patient service without direct patient contact first hour
Advance care planning by the physician or other qualified health care professional
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $65

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787743595

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787743606

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787743617

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787743629

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787743643

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 790253791

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: Rubraca

Open Associated Drug #1: 69660-201-91

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781016463

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $100

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781016465

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 796300133

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0576-22

Payments Total: $99

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 796300135

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0576-22

Hematology/oncology Professionals in Cumberland

1.
Blanche Mavromatis MD

12500 Willowbrook Rd
Cumberland, MD
Upmc Western Maryland Health Services Llc

2.
Blanche Mavromatis MD

12502 Willowbrook Rd
Cumberland, MD
Upmc Western Maryland Health Services Llc

3.
Vinita Singh

12500 Willowbrook Rd
Cumberland, MD
Upmc Western Maryland Health Services Llc

4.
Vinita Singh

12502 Willowbrook Rd
Cumberland, MD
Upmc Western Maryland Health Services Llc

5.
Nicholas Koutrelakos

12500 Willowbrook Rd
Cumberland, MD
Upmc Western Maryland Health Services Llc

6.
Nicholas Koutrelakos

12502 Willowbrook Rd
Cumberland, MD
Upmc Western Maryland Health Services Llc

Providers in the same medical group

1.Jon Aagaard

2001 N Gary Ave
Wheaton Il 60187-3055
Family Practice

2.Matthew Aaker

8055 W Ave
Castle Hills Tx 78213-1842
Optometry

3.Justin Aaker

3613 Williams Dr
Georgetown Tx 78628-1373
Ophthalmology

4.Mohammad Aalai

7005 35th Ave
Jackson Heights Ny 11372-3970
Physical Medicine And Rehabilitation

5.Carol Aalbers Cp

4560 S Carson St
Carson City Nv 89701-6915
Clinical Psychologist

6.Hina Aamir

602 S Atwood Rd
Bel Air Md 21014-4323
Psychiatry